Learn More
Apexbio Technology LLC Gilteritinib 1254053-43-4 10mg

Supplier: Apexbio Technology LLC A469110
Gilteritinib (CAS 1254053-43-4) also known as ASP2215 is a pyrazinecarboxamide derivative that functions as a selective inhibitor of FLT3 tyrosine kinase By targeting FLT3 gilteritinib disrupts aberrant signaling pathways associated with FLT3 mutations in hematologic malignancies while demonstrating minimal inhibition of c-Kit to reduce myelosuppressive effects observed with other FLT3 inhibitors Developed by Astellas Pharma gilteritinib is utilized in research focusing on FLT3-mutated acute myeloid leukemia and mechanisms of targeted kinase inhibition
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.